Article

Research to Prevent Blindness awards grant to OU Department of Ophthalmology

The University of Oklahoma Health Sciences Center has received an unrestricted grant from Research to Prevent Blindness for $575,000 over 5 years to support eye research conducted by the Department of Ophthalmology.

The University of Oklahoma Health Sciences Center (OUHSC) has received an unrestricted grant from Research to Prevent Blindness (RPB) for $575,000 over 5 years to support eye research conducted by the Department of Ophthalmology.

The funding has been awarded based on a thorough review of criteria, including the department’s research activities, laboratory environment, and clinical and scientific staff, as evaluated by RPB’s renowned Scientific Advisory Panel.

The funds will be deployed at the discretion of the Department Chair, to provide maximum flexibility in developing and expanding eye research programs, and to provide opportunities for creative planning that go beyond the scope of restricted project grants.

OUHSC holds one of only 30 RPB unrestricted grants nationwide.

“This grant will be critical to advancing our department’s scientific study of retinal degenerations, diabetic eye disease, infectious and inflammatory disease, and other conditions that can result in permanent vision loss,” said R. Michael Siatkowski, MD, MBA, the Edward L. Gaylord professor and chair of the University of Oklahoma (OU) Department of Ophthalmology and chief executive officer of the Dean McGee Eye Institute. “All of us at OU are extremely grateful to RPB for their generous support and the extraordinary impact it has had on the growth and success of our vision research programs.”

Since it was founded in 1960, RPB has channeled more than $397 million into eye research. As a result, RPB has been identified with nearly every major breakthrough in vision research during that time. For information on RPB’s grant program, listings of RPB institutional and individual grantees, and findings generated by these awards, go to www.rpbusa.org.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.